About ControlRad
ControlRad is a company based in Radnor (United States) founded in 2011 by Allon Guez. ControlRad has raised $41.11 million across 7 funding rounds from investors including Questa Capital and Rapha Capital Management. ControlRad operates in a competitive market with competitors including Radiaction, Texray, Burlington Medical, BLOXR Solutions and Barrier Technologies, among others.
- Headquarter Radnor, United States
- Founders Allon Guez
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.11 M (USD)
in 7 rounds
-
Latest Funding Round
$1 M (USD), Series B
Apr 06, 2022
-
Investors
Questa Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ControlRad
ControlRad has successfully raised a total of $41.11M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $1 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ControlRad
ControlRad has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Questa Capital and Rapha Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage VC and PE investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Rapha Capital Management is engaged in identifying and investing in biopharmaceutical companies.
|
Locked | Locked | Locked |
Investor details for ControlRad
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ControlRad
Investment portfolio details for ControlRad
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ControlRad
Detailed financials for ControlRad
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Controlrad Comparisons
Peer comparison for ControlRad
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ControlRad
ControlRad operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radiaction, Texray, Burlington Medical, BLOXR Solutions and Barrier Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Robotic radiation shielding systems are developed for interventional procedures.
|
|
| Locked | Locked | Locked |
Manufacturer of radiation protection textile for clinical practitioners
|
|
| Locked | Locked | Locked |
Radiation protection equipment for X-ray users is manufactured and supplied.
|
|
| Locked | Locked | Locked |
Manufacturer of radiation protection products
|
|
| Locked | Locked | Locked |
Barrier Technologies is recognized as a leading manufacturer of radiation protection products.
|
Detailed competitors of ControlRad
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Controlrad
Complete news archive for ControlRad
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ControlRad
ControlRad was founded in 2011 and raised its 1st funding round 1 year after it was founded.
ControlRad is headquartered in Radnor, United States. It is registered at Radnor, Pennsylvania, United States.
ControlRad is a funded company, having raised a total of $41.11M across 7 funding rounds to date.
Founded in 2011 and headquartered in Radnor, United States, ControlRad operates in the medical device sector. Devices are created for X-ray-guided interventional procedures, compatible with fixed and mobile C-arms. Eye-tracker technology is utilized to track physicians gaze and direct the X-ray beam to areas of interest. Tablet interfaces are also employed, enabling region-of-interest selection via touch for precise clinical focus.
ControlRad's top competitors include Radiaction, Barrier Technologies and Burlington Medical.
ControlRad has 2 investors. Key investors include Questa Capital, and Rapha Capital Management.